Protocol Village: VitaDAO, a ‘DeSci DAO,’ Launches Matrix Biosciences
The latest in blockchain tech upgrades, funding announcements and deals. For the week of Oct. 9-15, with live updates throughout. Source
Read More
VitaDAO
Pfizer-Backed VitaDAO Votes on Creating For-Profit Company to Fund Longevity Research
The company, to be called VitaTech, would leverage public funding to license longevity technologies developed in U.S. universities and support their continued development. The funds would come from research foundations and government grants such as the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR). Source
Read More
VitaDAO Closes $4.1M Funding Round With Pfizer Ventures for Longevity Research
VitaDAO was started in 2021 by Tyler Golato of decentralized biotech protocol Molecule to fund longevity research. According to the organization, it boasts a community of over 9,000 "enthusiasts, researchers and contributors," and deployed over $3.5 million to projects researching diseases of aging, cellular biology and repairing age-related damage to
Read More